Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Arsenic Trioxide in a Hemodialytic Patient with Acute Promyelocytic Leukemia

Acta Haematol (2009) 122 (1): 52–53.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Successful treatment of acute promyelocytic leukemia in a patient undergoing hemodialysis with arsenic trioxide
  • Akiko Hashimoto
  • Yasuhiro Tanaka
  • Isaku Shinzato
Clinical Case Reports (2021) 9 (7)
Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide
  • Akiko Hashimoto
  • Yasuhiro Tanaka
  • Takayuki Ishikawa
  • Isaku Shinzato
Clinical Case Reports (2021) 9 (7)
Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report
  • Hee Jeong Lee
  • Sang-Gon Park
World Journal of Clinical Cases (2020) 8 (21): 5347.
Chinese Medicine Might Be A Promising Way for A Solution to Arsenic Nephrotoxicity
  • Xue-zhong Gong
Chinese Journal of Integrative Medicine (2020) 26 (2): 83.
Effect of continuous venovenous haemodialysis on outcome and pharmacokinetics of arsenic species in a patient with acute promyelocytic leukaemia and acute kidney injury
  • Chunlu Gao
  • Shengjin Fan
  • Thomas H. Hostetter
  • Wenjing Wang
  • Jing Li
  • Meihua Guo
  • Jin Zhou
  • Xin Hai
British Journal of Clinical Pharmacology (2019) 85 (4): 849.
Management of patients with acute promyelocytic leukemia
  • Sabine Kayser
  • Richard F. Schlenk
  • Uwe Platzbecker
Leukemia (2018) 32 (6): 1277.
Use of arsenic trioxide in a hemodialysis-dependent patient with relapsed acute promyelocytic leukemia
  • Sarah Perreault
  • Julie Moeller
  • Kejal Patel
  • Rachel Eyler
  • Trinh Pham
  • Kerry Russell
  • Nikolai Podoltsev
Journal of Oncology Pharmacy Practice (2016) 22 (4): 646.
Tetramethylpyrazine (TMP) protects against sodium arsenite-induced nephrotoxicity by suppressing ROS production, mitochondrial dysfunction, pro-inflammatory signaling pathways and programed cell death
  • Xuezhong Gong
  • Vladimir N. Ivanov
  • Mercy M. Davidson
  • Tom K. Hei
Archives of Toxicology (2015) 89 (7): 1057.
Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis
  • Wing-Yan Au
  • Bonnie M. Fong
  • Sidney Tam
  • Yok-Lam Kwong
Annals of Hematology (2013) 92 (3): 417.
Relapsed acute promyelocytic leukemia in a hemodialysis-dependent patient treated with arsenic trioxide: a case report
  • Gregory S Emmons
  • Richard H Steingart
  • James A Stewart
  • Wilson C Mertens
Journal of Medical Case Reports (2012) 6 (1)
Arsenic trioxide for the treatment of a relapsed acute promyelocytic leukemia with acute renal failure
  • Hoi Soo Yoon
  • Tae Sung Park
  • Kyung Hwan Jeong
Pediatric Blood & Cancer (2011) 57 (6): 1085.
Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis
  • Yoshiki Tsuchiya
  • Yoshifumi Ubara
  • Tatsuya Suwabe
  • Junichi Hoshino
  • Keiichi Sumida
  • Rikako Hiramatsu
  • Eiko Hasegawa
  • Masayuki Yamanouchi
  • Noriko Hayami
  • Yuji Marui
  • Naoki Sawa
  • Fumi Takemoto
  • Kenmei Takaichi
Clinical and Experimental Nephrology (2011) 15 (3): 434.
Management of hematological malignancies in patients affected by renal failure
  • Pasquale Niscola
  • Gisella Vischini
  • Andrea Tendas
  • Laura Scaramucci
  • Marco Giovannini
  • Francesco Bondanini
  • Claudio Romani
  • Gregorio Antonio Brunetti
  • Claudio Cartoni
  • Luca Cupelli
  • Michele Ferrannini
  • Alessio Perrotti
  • Giovanni Del Poeta
  • Roberto Palumbo
  • Paolo de Fabritiis
Expert Review of Anticancer Therapy (2011) 11 (3): 415.
  • Online ISSN 1421-9662
  • Print ISSN 0001-5792
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal